- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06412913
Retrospective Study on Clinical Performance and Safety Profile of MJ-Flex Elastic Nail (MJ-Flex)
Multicenter Retrospective Observational Study to Assess the Clinical Performance and Safety Profile of MJ-FLEX in Paediatric Patients Who Have Suffered Diaphyseal Fractures of Long Bones in Daily Practice: MJ-FLEX Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is planned to be conducted in two investigational sites, one in France and one in United Kingdom, both experienced in the treatment of pediatric patients with diaphyseal fractures in the clavicle and in upper and lower limbs, where the usage of MJ-Flex The New Metaizeau Nail (known as MJ-Flex) was part of the normal clinical practice.
Investigator of both study sites will provide data for a maximum of 61 patients meeting inclusion and exclusion criteria (Considering a drop-out or a non-evaluable rate of 10% of the procedures) that will contribute for approximately 61 procedures in which MJ-Flex was used.
No diagnostic or therapeutic intervention outside of routine clinical practice will be applied. The study has been designed to analyze medical records of patients where study data was collected as part of their routine clinical practice. Therefore, patients will be retrospectively enrolled in the study. Patients who have undergone MJ-Flex implantation from 02/2018 to 12/2022 are considered for the study The observation period of study subjects will comprise from surgery until the last follow up visit available.
Medical records of the participating sites are expected to contain all the required information.
In United Kingdom, no study visit will be required but according to local legislation, it will be essential that before collecting any information from medical records, participants or their guardians are asked for specific informed consent to be signed by them before any collection of patient information takes place.
However, in France, due to the use of primary data and the foreseen exemption of the informed consent (IC) form (see Section 14.2 Informed Consent), no study visit will be required.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Edo Knijff
- Phone Number: +390456719000
- Email: EdoKnijff@orthofix.it
Study Contact Backup
- Name: Tommaso Marano
- Phone Number: +390456719000
- Email: tommasomarano@orthofix.it
Study Locations
-
-
-
Sheffield, United Kingdom, S10 2TH
- Sheffield Children's NHS Foundation Trust
-
Contact:
- Sara Dorman, MD
- Phone Number: +441142717000
- Email: sara.dorman@nhs.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patient has been adequately informed by providing the PIS. 1.1 The patient expressed his willingness to participate in the Study by signing and dating informed consent (valid only for UK patients according to local law).
- Patients who had a regular indication for surgical intervention with MJ-Flex according to the manufacturer's IFU.
- Patients in pediatric age (> 18 month and < 18 years) at the time of surgery.
- Patients skeletally immature.
- Patients who underwent surgery performed with MJ-Flex.
- Patients with clinical data registered in her/him medical records sufficient to assess the safety and efficacy endpoint of the study: in particular, the patient has at least one follow-up at minimum 3 months from the surgery where is possible for the investigator to assess the consolidation of the treated bone.
- The patient had surgery at least 1 year before enrollment.
Exclusion Criteria:
- Patient who had/has a medical condition that is a contraindication according to the manufacturer's instruction for use leaflet.
- Patient who had/has a concomitant not permitted device which cannot be safely removed.
- Patient for whom there are other concurrent medical or other conditions that in the opinion of the participating investigator may prevent participation or otherwise render the patient ineligible for the study.
- The patient had surgery less than 1 year before enrollment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients in pediatric age (> 18 month and < 18 years) at the time of surgery
The full analysis set includes all paediatric patients who that have been treated for diaphyseal fractures of long bones with the MJ-FLEX the will be systematically consecutive screened at the centers.
|
Intramedullary implantation of the MJ-Flex elastic nail in long bones to provide bone fixation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of procedures that have achieved bone union at the "bone consolidation assessment" visit
Time Frame: After 5 month (approximately) from surgery
|
The measurement of efficacy will be mande with the percentage of procedures that have achieved bone union
|
After 5 month (approximately) from surgery
|
Percentage of procedures who experienced at least one MDDs that caused an effect on the patient
Time Frame: from the date of surgery until the last follow-up, assessed up to 1 year
|
This outcome will be used to measure safety
|
from the date of surgery until the last follow-up, assessed up to 1 year
|
Percentage of procedures with at least one serious/not serious adverse event certainly related or possibly related to MJ-FLEX (ADEs/SADEs)
Time Frame: from the date of surgery until the last follow-up, assessed up to 1 year
|
This outcome will be used to measure safety
|
from the date of surgery until the last follow-up, assessed up to 1 year
|
Post-treatment fracture-free survival
Time Frame: up to 1 year
|
This outcome will be used to measure safety
|
up to 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sara Dorman, MD, Sheffield Children's NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OCI_2303
- 334519 (Other Identifier: IRAS project ID (UK))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractures, Bone
-
Lawson Health Research InstituteCompleted
-
AO Innovation Translation CenterRecruitingLong Bone FracturesUnited States, Canada, Australia, Ghana, Chile, China, Germany, India, Pakistan, Venezuela, Spain, Croatia, Greece
-
University Hospital, Clermont-FerrandTerminated
-
Centre Hospitalier Universitaire Saint PierreRecruiting
-
McMaster UniversityMcMaster Surgical AssociatesCompleted
-
IlluminOss Medical, Inc.CompletedHumerus Fracture Metastatic Bone DiseaseUnited States
-
University of UtahCompletedBone Strength | Stress Fractures | Bone Geometry | Biomechanical ChangesUnited States
-
University of British ColumbiaCompleted
-
Novo Nordisk A/SCompletedBone Fracture | Tibia FracturesIsrael, Germany, Finland, Hungary, Spain, South Africa, Norway, France, Poland
-
Carlos A Acosta-OlivoCompletedRadius Fractures | Bone Fractures | Closed Fractures
Clinical Trials on MJ-Flex The New Metaizeau Nail
-
Peifu TangRecruitingIntertrochanteric FractureChina